午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook >> journal list >> Clinical Pharmacokinetics >>article
Clinical Pharmacokinetics

Clinical Pharmacokinetics

IF: 4.59
Download PDF

A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin.

Published:1 October 2010 DOI: 10.2165/11536200-000000000-00000 PMID: 20818832
Howard N Bockbrader, David Wesche, Raymond Miller, Sunny Chapel, Nancy Janiczek, Paula Burger

Abstract

Pregabalin and gabapentin share a similar mechanism of action, inhibiting calcium influx and subsequent release of excitatory neurotransmitters; however, the compounds differ in their pharmacokinetic and pharmacodynamic characteristics. Gabapentin is absorbed slowly after oral administration, with maximum plasma concentrations attained within 3-4 hours. Orally administered gabapentin exhibits saturable absorption--a nonlinear (zero-order) process--making its pharmacokinetics less predictable. Plasma concentrations of gabapentin do not increase proportionally with increasing dose. In contrast, orally administered pregabalin is absorbed more rapidly, with maximum plasma concentrations attained within 1 hour. Absorption is linear (first order), with plasma concentrations increasing proportionately with increasing dose. The absolute bioavailability of gabapentin drops from 60% to 33% as the dosage increases from 900 to 3600 mg/day, while the absolute bioavailability of pregabalin remains at > or = 90% irrespective of the dosage. Both drugs can be given without regard to meals. Neither drug binds to plasma proteins. Neither drug is metabolized by nor inhibits hepatic enzymes that are responsible for the metabolism of other drugs. Both drugs are excreted renally, with elimination half-lives of approximately 6 hours. Pregabalin and gabapentin both show dose-response relationships in the treatment of postherpetic neuralgia and partial seizures. For neuropathic pain, a pregabalin dosage of 450 mg/day appears to reduce pain comparably to the predicted maximum effect of gabapentin. As an antiepileptic, pregabalin may be more effective than gabapentin, on the basis of the magnitude of the reduction in the seizure frequency. In conclusion, pregabalin appears to have some distinct pharmacokinetic advantages over gabapentin that may translate into an improved pharmacodynamic effect.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Pregabalin 148553-50-8 C8H17NO2 864 suppliers $44.00-$2480.00
Gabapentin 60142-96-3 C9H17NO2 833 suppliers $9.35-$775.00

Similar articles

IF:3.2

Gabapentin and pregabalin in dermatology.

Indian Journal of Dermatology Venereology & Leprology Asit Mittal, Chesta Agarwal,etc Published: 1 September 2018
IF:1.9

A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.

European Journal of Drug Metabolism and Pharmacokinetics Kyle John Wilby,etc Published: 1 June 2018
IF:4.6

Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review.

Clinical Pharmacokinetics T Y J Appeldoorn, T H Oude Munnink,etc Published: 1 April 2023